Table 3.

Study-specific parameters: posterior summaries from the preferred model

	Proportion of neonates with adverse outcomes in the absence of maternal Zika virus infection	Proportion of women in comparison group with Zika virus infection in pregnancy
Pomar et al (2018)16	9% (2–15)	..
Nogueira et al (2018)18	17% (4–33)	..
Hoen et al (2018)17	1% (0–4)	..
Rodó et al (2019)19	13% (9–19)	2% (0–16)
Brasil et al (2016)15	13% (2–29)	12% (1–49)
Merriam et al (2020)21	11% (2–22)	26% (1–91)
Conners et al (2017)20	..	52% (23–94)

Data are median (95% credible interval).